What You Should Know:
– Trinity Biotech, a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, today unveiled its new flagship product, CGM+, a next-generation wearable biosensor platform designed for the $260 billion AI wearables market.
– Now in the later stages of device development, CGM+ is Trinity’s new AI-native continuous glucose monitoring (CGM) system, combining multi-sensor data and real-time analytics to meet the evolving demands of AI-powered healthcare and wellness.
Optimizing Continuous Glucose Monitoring
Unlike traditional CGMs that focus solely on glucose monitoring, CGM+ integrates an ultra-thin, minimally invasive electrochemical glucose sensor with continuous monitoring of heart activity, body temperature, and physical activity—all within a single, sleek, and user-friendly modular wearable device. This multimodal data stream is being optimized for real-time AI analysis, enabling a deeper, more contextual understanding of metabolic and physiological health. Trinity Biotech has identified these expanded data points as critical for gaining insights into essential metabolic factors like sleep, stress, and physical activity.
Trinity Biotech’s proprietary needle-free glucose sensor technology facilitates the collection of expanded data points from a single modular wearable device. This innovative design not only reduces disposable components and waste but also significantly lowers the cost of care compared to current leading market products.
“CGM+ is not just a device—it’s a proprietary data engine we are building for the AI health ecosystem,” said John Gillard, CEO of Trinity Biotech. “We believe this technology can power the next wave of personalized, predictive, and preventative care—while opening up entirely new commercial pathways for Trinity Biotech, from device sales to AI-driven data services. It will also position us to compete well beyond traditional diagnostics, at the intersection of chronic disease management, digital health and consumer wellness.”
Real-Time AI-Driven Healthcare
As healthcare shifts toward precision medicine and continuous, real-world data collection, CGM+ is positioned to become a critical enabler of AI-based diagnostics, behavioral coaching, and chronic disease management. Engineered from the ground up, CGM+ is designed to serve as a foundational platform for AI-native health applications:
- Comprehensive Multi-sensor Intelligence: Combines glucose, cardiovascular, thermoregulation, and physical activity data for a holistic view of health and wellness.
Clinical and Consumer Lifestyle Use Cases: Designed to support both regulated clinical workflows and consumer wellness applications, bridging the gap between medical-grade monitoring and everyday health optimization.
